ENDOCYTE INC 4
4 · ENDOCYTE INC · Filed Aug 13, 2014
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Lovejoy Chandra D
VP of Regulatory Affairs
Transactions
- Sale
Common Stock
2014-08-11$7.00/sh−21,479$150,353→ 6,250 total - Exercise/Conversion
Common Stock
2014-08-11$3.06/sh+479$1,466→ 6,729 total - Exercise/Conversion
Common Stock
2014-08-11$3.55/sh+21,000$74,550→ 27,729 total - Award
Stock Option (right to buy)
2014-08-11+479→ 0 totalExercise: $3.06Exp: 2017-11-14→ Common Stock (479 underlying) - Award
Stock Option (right to buy)
2014-08-11+21,000→ 17,443 totalExercise: $3.55Exp: 2022-02-28→ Common Stock (21,000 underlying)
Footnotes (3)
- [F1]The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
- [F2]This option is fully vested and immediately exercisable.
- [F3]Shares subject to the option vest 1/4 annually over a period of 4 years beginning on February 29, 2013.